W H M Verbeek
Overview
Explore the profile of W H M Verbeek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rubio-Tapia A, Malamut G, Verbeek W, van Wanrooij R, Leffler D, Niveloni S, et al.
Aliment Pharmacol Ther
. 2016 Aug;
44(7):704-14.
PMID: 27485029
Background: Refractory coeliac disease is a severe complication of coeliac disease with heterogeneous outcome. Aim: To create a prognostic model to estimate survival of patients with refractory coeliac disease. Methods:...
2.
Tack G, Wondergem M, Al-Toma A, Verbeek W, Schmittel A, Machado M, et al.
Bone Marrow Transplant
. 2010 Sep;
46(6):840-6.
PMID: 20818442
Autologous hematopoietic SCT (auto-SCT) has been effective therapy for refractory disease, in both malignancies and severe autoimmune diseases. It seems feasible and safe for refractory celiac disease (RCD) type II,...
3.
van Wanrooij R, Schreurs M, Bouma G, von Blomberg B, Tack G, Verbeek W, et al.
Gut
. 2010 Sep;
59(12):1732.
PMID: 20805314
No abstract available.
4.
Verbeek W, von Blomberg B, Coupe V, Daum S, Mulder C, Schreurs M
Cytometry B Clin Cytom
. 2009 May;
76(6):367-74.
PMID: 19444812
Background: Refractory coeliac disease (RCD) is characterized by persisting mucosal pathology in spite of a strict gluten free diet (GFD). In RCD type II, phenotypically aberrant (CD7+CD3-CD4/8-cytoplasmicCD3+) T-lymphocytes are present...
5.
Trynka G, Zhernakova A, Romanos J, Franke L, Hunt K, Turner G, et al.
Gut
. 2009 Feb;
58(8):1078-83.
PMID: 19240061
Objective: Our previous coeliac disease genome-wide association study (GWAS) implicated risk variants in the human leucocyte antigen (HLA) region and eight novel risk regions. To identify more coeliac disease loci,...
6.
Verbeek W, Mulder C
Gastroenterol Clin Biol
. 2008 Apr;
32(3):e3-4.
PMID: 18423929
No abstract available.
7.
Verbeek W, Mulder C
Gastroenterol Clin Biol
. 2008 Apr;
32(3):234-5.
PMID: 18406551
No abstract available.
8.
Al-Toma A, Verbeek W, Mulder C
Dig Dis
. 2007 Sep;
25(3):230-6.
PMID: 17827946
Refractory celiac disease (RCD) is being defined as persisting or recurring villous atrophy with crypt hyperplasia and increased intraepithelial lymphocytes (IELs) in spite of a strict gluten-free diet (GFD) for...
9.
Al-Toma A, Verbeek W, Visser O, Kuijpers K, Oudejans J, Kluin-Nelemans H, et al.
Dig Liver Dis
. 2007 May;
39(7):634-41.
PMID: 17531561
Background: Despite treatment, enteropathy-associated T-cell lymphoma has a very poor outcome. Chemotherapy can be complicated by small bowel perforation, gastrointestinal bleeding and development of enterocolic fistulae. Here we report on...
10.
Al-Toma A, Verbeek W, Hadithi M, von Blomberg B, Mulder C
Gut
. 2007 May;
56(10):1373-8.
PMID: 17470479
Background: Coeliac disease may be regarded as refractory disease (RCD) when symptoms persist or recur despite strict adherence to a gluten-free diet. RCD may be subdivided into types I and...